A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA

BACKGROUND: Digoxin was found to inhibit prostate cancer (PCa) growth via the inhibition of HIF-1α synthesis in a mouse model. We hypothesized that a therapeutic dose of digoxin could inhibit human PCa growth and disease progression. METHODS: An open label, single arm pilot study was performed. Pati...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Cancer Ther Pharmacol
Auteurs principaux: Lin, Jianqing, Zhan, Tingting, Duffy, Danielle, Hoffman-Censits, Jean, Kilpatrick, Deborah, Trabulsi, Edouard J., Lallas, Costas D., Chervoneva, Inna, Limentani, Kimberly, Kennedy, Brooke, Kessler, Sarah, Gomella, Leonard, Antonarakis, Emmanuel S., Carducci, Michael A., Force, Thomas, Kelly, Wm. Kevin
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287984/
https://ncbi.nlm.nih.gov/pubmed/25580468
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires